Cargando…
Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals
BACKGROUND: Hepatitis C virus (HCV) infection is a documented risk factor for chronic kidney disease (CKD) and progression to end-stage renal disease (ESRD). However, to date there are no reports on the long-term hard endpoints (ESRD and death) of anti-HCV therapy [interferon-based therapy (IBT) or...
Autores principales: | Chen, Yi-Chun, Li, Chung-Yi, Tsai, Shiang-Jiun, Chen, Yen-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580345/ https://www.ncbi.nlm.nih.gov/pubmed/31236391 http://dx.doi.org/10.12998/wjcc.v7.i11.1270 |
Ejemplares similares
-
Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection
por: Chen, Yi-Chun, et al.
Publicado: (2018) -
Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication
por: Lu, Ming-Ying, et al.
Publicado: (2022) -
Predictors of unfavorable outcome at 90 days in basilar artery occlusion patients
por: Chiu, Yu-Chen, et al.
Publicado: (2022) -
No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer
por: Wu, Yun-Zi, et al.
Publicado: (2022) -
Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib
por: Meng, Xiao-Chun, et al.
Publicado: (2018)